Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing amylase and endopeptidase and pancreatic lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amylase and endopeptidase and pancreatic lipase only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amylase and endopeptidase and pancreatic lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase and pancreatic lipase and pancreatic protease only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase and pancreatic lipase and pancreatic protease only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing pancreatic amylase and pancreatic lipase and pancreatic protease in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing pancreatic amylase and pancreatic lipase and pancreatic protease (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) |
Has precise active ingredient |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Pancreatic lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |